Understanding Treatment Strategies and Preferences in Nonmetastatic Castration-Resistant Prostate Cancer From the Japanese Physician Perspective.
Kazuhiro SuzukiVince GrilloYirong ChenShikha SinghDianne Athene LedesmaPublished in: JCO global oncology (2021)
Physicians preferred a treatment with better safety profile, and treatment characteristics were the most important factors for decision making. This might have implications in physicians' decision making for nmCRPC treatment in the future in Japan.